Ndwm LLC bought a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) during the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 6,358 shares of the exchange traded fund’s stock, valued at approximately $603,000. SPDR S&P Biotech ETF makes up approximately 0.5% of Ndwm LLC’s investment portfolio, making the stock its 19th biggest holding.
Other institutional investors and hedge funds also recently made changes to their positions in the company. ICA Group Wealth Management LLC purchased a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $27,000. Scarborough Advisors LLC bought a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth $32,000. BOCHK Asset Management Ltd purchased a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter valued at $36,000. Tennessee Valley Asset Management Partners bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth $44,000. Finally, Wetzel Investment Advisors Inc. purchased a new position in SPDR S&P Biotech ETF in the fourth quarter worth $45,000.
SPDR S&P Biotech ETF Price Performance
NYSEARCA XBI traded down $0.49 during trading hours on Thursday, reaching $90.87. 4,682,011 shares of the stock traded hands, compared to its average volume of 10,621,511. The stock has a 50 day simple moving average of $90.41 and a two-hundred day simple moving average of $90.94. SPDR S&P Biotech ETF has a 1 year low of $63.80 and a 1 year high of $103.52. The company has a market cap of $6.93 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.
Featured Articles
- Five stocks we like better than SPDR S&P Biotech ETF
- Why Are Stock Sectors Important to Successful Investing?
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- Investing in Commodities: What Are They? How to Invest in Them
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Best Stocks Under $5.00
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.